使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Operator
Thank you for standing by, and welcome to the first quarter 2024 Knowles Corporation earnings conference call. All lines have been placed on mute to prevent any background noise After the speakers' remarks, there will be a question and answer session. (Operator Instructions)
感謝各位稍候,歡迎參加 Knowles Corporation 2024 年第一季財報電話會議。為避免任何背景噪音,所有線路均已設為靜音。講者發言結束後,將進行問答環節。(接線員指示)
Thank you. I would now like to turn the call over to Sarah Cook. Please go ahead.
謝謝。現在我想把電話會議交給 Sarah Cook。請開始。
Sarah Cook - IR
Sarah Cook - IR
Thank you and welcome to our Q1 2024 earnings call. I'm Sarah Cook, Vice President of Investor Relations. And presenting with me today are Jeffrey Niew, our President and CEO; and John Anderson, our Senior Vice President and CFO.
謝謝,歡迎參加我們 2024 年第一季財報電話會議。我是 Sarah Cook,投資人關係副總裁。今天與我一同出席的有:我們的總裁暨執行長 Jeffrey Niew,以及資深副總裁暨財務長 John Anderson。
Our call today will include remarks about future expectations, plans and prospects for Knowles, which constitute forward-looking statements for purposes of the Safe Harbor provisions under applicable federal securities laws.
今天的電話會議將包含關於 Knowles 未來預期、計畫與展望的評論,這些內容依適用之聯邦證券法「安全港」條款之目的構成前瞻性陳述。
Forward-looking statements in this call will include comments about demand for company product, anticipated trends and company sales expenses and profits, and involve a number of risks and uncertainties that could cause actual results to differ materially from current expectations.
本次電話會議中的前瞻性陳述將包括對公司產品需求、預期趨勢以及公司銷售、費用與獲利的評論,並涉及多項風險與不確定性,可能導致實際結果與目前預期出現重大差異。
The company urges investors to review the risks and uncertainties in the company's SEC filings, including, but not limited to our annual report on Form 10-K for the fiscal year ended December 31, 2023, periodic reports filed from time to time with the SEC and the risks and uncertainties identified in today's earnings release.
公司敦促投資人檢視公司向 SEC 提交文件中的風險與不確定性,包括但不限於截至 2023 年 12 月 31 日止會計年度的 Form 10-K 年度報告、不時向 SEC 提交的定期報告,以及今日財報新聞稿中所辨識的風險與不確定性。
All forward-looking statements are made as of the date of this call, and Knowles disclaims any duty to update such statements except as required by law. In addition, pursuant to Reg G, any non-GAAP financial measures referenced during today's conference call can be found in our press release posted on our website at knowles.com, and in our current report on Form 8-K filed today with the SEC, including a reconciliation to the most directly comparable GAAP measure.
所有前瞻性陳述均以本次電話會議日期為準,除法律要求外,Knowles 不承擔更新該等陳述之任何義務。此外,依 Reg G 規定,今日電話會議中提及的任何非 GAAP 財務衡量指標,均可在我們網站 knowles.com 上發布的新聞稿,以及今日向 SEC 提交的 Form 8-K 當期報告中查閱,並包含與最直接可比 GAAP 指標的調節表。
All financial references on this call will be made on a non-GAAP continuing operations basis, unless otherwise indicated. We've made selected financial information available and webcast slides, which can be found in the Investor Relations section of our website.
除非另有說明,本次電話會議中所有財務數據均以非 GAAP 的持續營運基礎呈現。我們已提供部分財務資訊與網路直播簡報投影片,可於我們網站的投資人關係(Investor Relations)專區查閱。
With that, let me turn the call over to Jeff, who will provide details on our results. Jeff?
接下來,我把電話會議交給 Jeff,由他說明我們的業績細節。Jeff?
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Thanks, Sarah, and thanks to all of you for joining us today. I'm very pleased with the start of 2024 as our first quarter results showed the potential of our businesses to expand EBIT margins and drive strong free cash flow. We are continuing to -- our transformation to focus on high-growth end markets where we have differentiated solutions and our Q1 financial performance is evidence that our strategy is working.
謝謝 Sarah,也感謝各位今天加入我們。我對 2024 年的開局感到非常滿意,因為第一季的結果展現了我們各項業務擴大 EBIT 利潤率並推動強勁自由現金流的潛力。我們持續推進轉型,聚焦於我們具備差異化解決方案的高成長終端市場,而第一季的財務表現證明我們的策略正在奏效。
In the first quarter, we delivered revenue of $196 million above the midpoint of our guided range. EPS of $0.20 at the high end of our guided range and cash from operations of $17 million which exceeded the high end of our guided range.
第一季我們的營收為 1.96 億美元,高於指引區間的中點。每股盈餘(EPS)為 0.20 美元,位於指引區間高端;營運活動現金流為 1,700 萬美元,亦超過指引區間高端。
Turning to segment results, MedTech and specialty audio revenue was up 26% with over 90% adjusted EBIT growth versus the same period a year ago. The end markets for our hearing health products remain robust as market dynamics, such as aging populations, expansion of middle class globally and improved hearing aid penetration, all remain favorable.
就部門表現而言,MedTech 與專業音訊營收成長 26%,調整後 EBIT 較去年同期成長超過 90%。我們的聽力健康產品終端市場仍然強勁,人口老化、全球中產階級擴張以及助聽器滲透率提升等市場動態皆持續有利。
Second, our operational excellence continues to produce strong margin performance. This, coupled with our success in new product adoption, is driving revenue growth with expanding EBIT margins and cash flow for 2024. Precision Device revenue was up 38% from a year ago driven by the acquisition of Cornell.
第二,我們的營運卓越持續帶來強勁的利潤率表現。再加上我們在新產品導入上的成功,正推動 2024 年營收成長、EBIT 利潤率擴張以及現金流提升。Precision Device(精密裝置)營收較去年成長 38%,主要受惠於收購 Cornell。
As we expected, the end market challenges we experienced in the back half of 2023 continued into the first half of 2024 as inventory levels within distribution and the industrial end markets remain high. We remain focused on design activity, which continues to be robust in defense, life sciences, industrial and EV and positions us well for future growth.
如我們所預期,2023 年下半年所經歷的終端市場挑戰延續至 2024 年上半年,因為通路與工業終端市場的庫存水位仍偏高。我們仍聚焦於設計導入活動;在國防、生命科學、工業與電動車(EV)領域的設計活動依然強勁,為未來成長奠定良好基礎。
We continue to be excited about the performance synergistic opportunities and total available market expansion Cornell brings to the PD segment. With the beginning of an anticipated recovery in the second half of the year and the addition of Cornell we expect to see double digit revenue and adjusted EBIT growth within this segment in 2024.
我們持續對 Cornell 為 PD 部門帶來的績效協同機會與可服務市場(TAM)擴張感到振奮。隨著預期下半年開始復甦,加上 Cornell 的加入,我們預期 2024 年該部門將實現營收與調整後 EBIT 的雙位數成長。
Before moving to the results for the consumer mems microphone business, I will provide some brief commentary on the status of the strategic alternatives process that we announced last year. We are taking into consideration all the stakeholders from customers to suppliers and shareholders to employees and I believe we are progressing to a conclusion.
在談到消費性 MEMS 麥克風業務的結果之前,我先簡要說明我們去年宣布的策略替代方案評估流程的最新狀態。我們正將所有利害關係人納入考量,從客戶到供應商、從股東到員工;我相信我們正朝著結論推進。
From an operational standpoint, CMM's financial result in the quarter were solid. Revenue was up 44% from the same period a year ago, as the business has returned to more stabilized levels. We've expanded our mobile and ear share and expecting to continue to see revenue growth in the second quarter and for the full year 2024, as compared to 2023 levels.
就營運面而言,CMM 本季的財務結果穩健。營收較去年同期成長 44%,因為該業務已回到較為穩定的水準。我們擴大了在手機與耳機端的市占,並預期第二季及 2024 全年營收相較 2023 年水準將持續成長。
In closing, we expect to continue to generate robust cash from operations in Q2 and the remainder of 2024, despite excess share inventory negatively impacting demand within our PD segment. Our cash generation and strong balance sheet will allow us to explore acquisition opportunity, buy back shares and keep our debt at manageable levels.
最後,我們預期在第二季及 2024 年剩餘期間,儘管 PD 部門因通路庫存過剩而對需求造成負面影響,仍將持續產生強勁的營運活動現金流。我們的現金創造能力與強健的資產負債表,將使我們得以探索併購機會、回購股份,並將負債維持在可控水準。
I am pleased with the financial performance to date in 2024 and I'm excited about the opportunities we have ahead of us. We are confident in our ability to deliver shareholder value as we continue to drive operational execution excellence, execute on design wins in all three segments and expand our share across our businesses.
我對 2024 年迄今的財務表現感到滿意,也對未來的機會感到振奮。隨著我們持續推動卓越的營運執行、在三個部門全面落實設計導入(design wins),並擴大各項業務的市占,我們對創造股東價值的能力充滿信心。
Now let me turn the call over to John to detail our quarter results and provide some guidance.
現在我把電話會議交給 John,請他詳述本季業績並提供指引。
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
Thanks, Jeff. We reported first quarter revenues of $196 million above the midpoint of guidance and up 36% from the year ago period, driven by double digit growth in all three segments. EPS was $0.20 in the quarter at the high end of our guidance range and $0.15 above the year-ago period, driven by increased gross profit associated with higher shipment volume, partially offset by higher interest expense.
謝謝 Jeff。我們第一季營收為 1.96 億美元,高於指引中點,較去年同期成長 36%,主要由三個部門皆達雙位數成長所帶動。本季 EPS 為 0.20 美元,位於指引區間高端,較去年同期增加 0.15 美元;主要受惠於出貨量提升帶動毛利增加,但部分被利息費用上升所抵銷。
In the MedTech and specialty audio segment revenue was $57 million, up 26% versus the first quarter of 2023 and increased demand in the hearing health market as customer inventories have returned to normal levels. Gross margins were 54.8%, up 1,130 basis points versus the prior year, driven by improved factory performance and favorable product mix.
在 MedTech 與專業音訊部門,營收為 5,700 萬美元,較 2023 年第一季成長 26%;隨著客戶庫存回到正常水位,聽力健康市場需求增加。毛利率為 54.8%,較去年提升 1,130 個基點,主要受惠於工廠績效改善與有利的產品組合。
The precision devices segment delivered revenues of $74 million, up 38% from the year ago period, driven by the acquisition of Cornell, partially offset by lower shipments into the distribution and industrial end markets as channel and customer inventory levels remain elevated.
精密裝置部門營收為 7,400 萬美元,較去年同期成長 38%,主要由收購 Cornell 所帶動;但由於通路與客戶庫存水位仍偏高,對通路與工業終端市場的出貨較低,部分抵銷了成長。
Gross margins were 36.1%, down 1,100 basis points from prior year levels due to lower factory capacity utilization and the acquisition of Cornell. Consumer MEMS microphone revenues of $65 million were up 44% versus the year ago period due to increased consumer demand and share gains in mobile, ear and compute markets.
毛利率為 36.1%,較去年下降 1,100 個基點,原因為工廠產能利用率較低以及收購 Cornell 的影響。消費性 MEMS 麥克風營收為 6,500 萬美元,較去年同期成長 44%,主要受惠於消費需求增加,以及在手機、耳機與運算(compute)市場的市占提升。
Gross margins were 26.2%, 450 basis points above Q1 2023 on improved factory capacity utilization, partially offset by lower pricing. On a total company basis, R&D expense in the quarter was $16.7 million, flat compared to the prior year. SG&A expenses were $32 million, $5 million higher than prior year levels driven by the acquisition of Cornell, partially offset by the benefits of prior restructuring actions taken in both the Precision Devices and CMM segments.
毛利率為26.2%,較2023年第一季高出450個基點,主要受惠於工廠產能利用率提升,但部分被較低的定價所抵銷。以全公司口徑計,本季研發費用為1,670萬美元,與去年同期持平。銷售、一般及行政(SG&A)費用為3,200萬美元,較去年同期高出500萬美元,主要由於收購Cornell所致,但部分被精密裝置(Precision Devices)與CMM部門先前採取的重整措施所帶來的效益所抵銷。
Interest expense was up $4 million versus the prior year due to the acquisition of Cornell in the fourth quarter of 2023. Now I'll turn to our balance sheet and cash flow. In the first quarter, we generated $17 million in cash from operating activities above the high end of our guidance, driven by higher customer collections and lower than expected inventory levels.
利息費用較去年同期增加400萬美元,原因是於2023年第四季收購Cornell。接下來我將說明我們的資產負債表與現金流。第一季我們自營運活動產生1,700萬美元現金,優於我們指引區間的上緣,主要由於客戶回款增加,以及庫存水位低於預期。
Capital spending was $3 million. We ended the quarter with cash and cash equivalents of $122 million. We exited the first quarter of 2024 with $293 million of debt, which includes $180 million of borrowings under our revolving credit facility and an interest free seller note, which was issued in connection with the Cornell acquisition.
資本支出為300萬美元。本季末我們的現金及約當現金為1.22億美元。我們在2024年第一季末的債務為2.93億美元,其中包括循環信用額度項下借款1.80億美元,以及一張無息賣方票據(seller note),該票據係與收購Cornell相關而發行。
Lastly, our net leverage ratio based on trailing 12-months EBITDA was 1.1 times. Moving to our guidance for the second quarter of 2024, revenues are expected to be between $199 million and $209 million, up 18% versus the year ago period, driven primarily by the acquisition of Cornell.
最後,以過去12個月EBITDA計算的淨槓桿比率為1.1倍。接著談2024年第二季指引,預期營收介於1.99億至2.09億美元,較去年同期成長18%,主要由收購Cornell所帶動。
R&D expenses are expected to be between $16 million and $18 million, and selling and administrative expenses are expected to be within the range of $29 million to $31 million, up from prior year due to the Cornell acquisition.
研發費用預期介於1,600萬至1,800萬美元;銷售與管理費用預期介於2,900萬至3,100萬美元,較去年同期增加,係因收購Cornell所致。
We're projecting adjusted EBIT margin for the quarter to be within a range of 14% to 16%. We're forecasting interest expense in Q2 to be approximately $5 million, which includes $2 million of non-cash imputed interest. And we expect an effective tax rate of 14% to 16% for both the quarter and full year 2024.
我們預估本季調整後EBIT利潤率將落在14%至16%之間。我們預估第二季利息費用約為500萬美元,其中包含200萬美元的非現金推算利息(imputed interest)。我們預期本季及2024年全年有效稅率為14%至16%。
We're projecting EPS to be within a range of $0.22 to $0.26 per share. This assumes weighted average shares outstanding during the quarter of $93 million on a fully diluted basis. We're projecting cash from operations to be within a range of $20 million to $30 million, and capital spending is expected to be $5 million.
我們預估每股盈餘(EPS)將介於每股0.22至0.26美元。此假設本季完全稀釋後的加權平均流通股數為9,300萬股。我們預估營運活動現金流將介於2,000萬至3,000萬美元,資本支出預期為500萬美元。
I will now turn the call back over to the operator for the questions and answers portion of the call. Operator?
我現在把電話交回給接線員,進入問答環節。接線員?
Operator
Operator
Thank you. We will now begin the question-and-answer session. (Operator Instructions)
謝謝。我們現在開始問答環節。(接線員指示)
Christopher Rolland, Susquehanna.
Christopher Rolland,Susquehanna。
Chris Rolland - Analyst
Chris Rolland - Analyst
Thanks for the question. I guess for my first one, if you guys could dig into the profile of that back half recovery, like what kind of sequential should we be expecting in our double digit variety or kind of the single digit variety and Yes. Like any other color by segment would for, of course, Q2. But the profile for the rest of the year would be great as well, if you can give that.
謝謝讓我提問。我想先問第一個,如果你們能深入說明一下下半年復甦的輪廓,例如我們應該預期環比成長是雙位數的類型,還是單位數的類型,以及是的。另外也想請你們就各部門提供一些補充說明,當然包含第二季。但如果也能談談今年剩餘期間的輪廓就更好了,若你們可以提供的話。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Yes, Chris, thanks for the question. Good question. So let me just kind of break it out by segment and then I'll kind of summarize it again. But first, on the PD segment on. I think what we're expecting now is we had of Q1 to Q2, we are seeing sequential growth in the PT segment. We expect to see sequential growth again in Q3 and in Q4 right now, we expect that in just a little color around that. I think we're probably a little bit of more, I would say, a cautious now on industrial and distribution in the rate of a rising, it's still going up sequentially, but not quite as much.
好的,Chris,謝謝你的提問。好問題。我先按部門拆解說明,然後再做個總結。首先是PD部門。我想我們目前的預期是,從第一季到第二季,我們看到PT部門出現環比成長。我們也預期第三季與第四季將再次出現環比成長;我再補充一點背景。我認為我們對工業與通路端目前可能稍微更為審慎一些,成長仍會逐季上升,但幅度沒有那麼大。
And I would say more of our OEM customers, no bigger OEM customers, net new defense, we see more growth there. And so your overall for PD again, we're going to see, I would say, pretty decent sequential growth in the back half of the year, but probably more heavily weighted towards the fourth quarter.
而我會說,我們更多的OEM客戶、一些較大的OEM客戶,以及新增的國防業務,我們看到那邊有更多成長。因此就PD整體而言,下半年我們仍將看到相當不錯的逐季成長,但可能會更偏重在第四季。
On second in MSA, I think they're they're hitting on all cylinders. They're doing very well. The market's very strong our execution, our new products, and we're doing very well in this market.
第二個是MSA,我認為他們是火力全開。他們表現非常好。市場非常強勁,加上我們的執行力與新產品,我們在這個市場做得很好。
And I just would remind you is Q4 is typically our largest quarter. There's a big you're hearing a launch of products in two three, which kind of drives revenue in Q4. So we would expect that while we'll see some sequential growth now going forward in this, it's really going to come in Q4.
我也提醒一下,第四季通常是我們最大的一季。你們會聽到在第二、第三季有產品上市,這會在第四季帶動營收。因此我們預期,雖然接下來會看到一些逐季成長,但真正明顯的成長會出現在第四季。
And then lastly, on your I think, CMM, you normally have seasonally higher in the back half than the front half. I would think we're we're cautiously more optimistic about the back half than we say we're three months ago. And so I think overall, I think low when I look at that, I'd say again, probably a little bit more heavily weighted to the fourth quarter, but we do expect to have nice sequential growth from Q2 to Q3 and then even a little bit more from Q3 to Q4.
最後是CMM,我認為通常下半年季節性會比上半年更高。我想我們對下半年的看法,比三個月前更審慎地偏向樂觀。因此整體來看,我會說可能仍稍微更偏重第四季,但我們確實預期從第二季到第三季會有不錯的逐季成長,且從第三季到第四季還會再多一些。
Chris Rolland - Analyst
Chris Rolland - Analyst
Thank you so much, Jeff. That's so helpful. The second one is around the appetite for the CMM business or progress there. And then any update more broadly you might have on M&A?
非常感謝你,Jeff。這很有幫助。第二個問題是關於CMM業務的意願(appetite)或目前進展。另外,你們在併購(M&A)方面是否有更廣泛的最新進展可以更新?
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Sure. Let me take the first second question first. I think if you look at our leverage ratio, as John mentioned, -
當然。我先回答第二個問題的第一部分。我想如果你看我們的槓桿比率,如John剛才提到的,-
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
Just a touch over one.
略高於1。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Just a touch over one. If you look out through the full year with the cash we expect to generate, I think we'll probably be something south of 0.8 leverage ratio by the end of the year. And so with that kind of leverage ratio, we're looking in the marketplace. Of course, we're going to be super disciplined in what we do, kind of like how we know, again, I bring up Cornell.
略高於1。如果你把時間拉到全年,考量我們預期將產生的現金,我認為到年底我們的槓桿比率可能會降到0.8以下。在這樣的槓桿水準下,我們會在市場上尋找機會。當然,我們會非常嚴謹自律地執行,就像我們所知道的那樣——我再提一次Cornell。
We are very pleased with this acquisition. I continue to feel very good that despite some of the challenges in industrial and distribution, it's still performing to the levels that we kind of announced when the when the deal was announced. And so I think we're very excited to look for other acquisition opportunities and hopefully they'll build little ones will come along.
我們對這次收購非常滿意。我仍然覺得非常有信心:儘管工業與通路端有一些挑戰,它的表現仍達到我們在宣布交易時所提到的水準。因此我們也很期待尋找其他收購機會,希望接下來會出現一些較小型的案子。
That makes sense relative to advancing kind of our strategic positioning.
相較於推進我們的策略定位,這樣就說得通。
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
If I could just add, too. I mean, Jeff mentioned here, we do expect our leverage to come down a bit over 2024. In addition, we expect to continue to repurchase shares and we think our stock price is undervalued. So it will be a combination of share buybacks and paydown of debt.
如果我也可以補充一下。我是說,Jeff 在這裡提到,我們確實預期 2024 年我們的槓桿會稍微下降。此外,我們預期會持續回購股票,而且我們認為股價被低估。所以這將會是股票回購與償還債務的組合。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
As far as the amount, I think I don't have too much more to say. Maybe I'll just kind of like say it might be my own non-scripted words, but there's a lot of stakeholders in play and place here. And I think we've kind of been very clear that that you'll obviously, post whatever happens with CMM. We do still have our MSA business, which will be selling mems microphones. And so I think I kind of said, our employees are our -- I'm saying to our shareholders, I say, to our suppliers.
至於金額方面,我想我沒有太多可以再補充的。也許我就用一些非照稿的話來說,但這裡牽涉到很多利害關係人。而且我想我們已經很清楚地表示,無論 CMM 最後發生什麼事,事後你都會看到。我們仍然有 MSA 業務,會銷售 MEMS 麥克風。所以我想我剛才也提到,我們的員工是我們的——我是對股東說,也對供應商說。
Yes, I think it's -- we're taking a little bit more time than probably people would have bought. But I think we're being very thoughtful about what we do. And but I do think we're getting closer to a conclusion. We are progressing towards a conclusion. And so I think you could take for that what that means. But but I think we're kind of narrowing in on what the direction we're going to go.
是的,我想——我們花的時間可能比大家原本預期的稍微久一些。但我想我們對要做的事情非常審慎。不過我確實認為我們正接近結論。我們正在朝著結論推進。所以我想你可以自行解讀這代表什麼。但我想我們正在逐步收斂要走的方向。
Chris Rolland - Analyst
Chris Rolland - Analyst
Great update. Thanks guys.
更新得很好。謝謝各位。
Operator
Operator
Bob Labick, CJS Securities.
Bob Labick,CJS Securities。
Pete Lukas - Analyst
Pete Lukas - Analyst
Yes, hey, it's Pete Lukas for Bob. You covered a lot and answered a lot of my questions. Just one here for you and just an update on the integration and synergies of CD, and how is pricing power and do you still think margins can be increased?
是的,嗨,我是代替 Bob 的 Pete Lukas。你們涵蓋了很多內容,也回答了我很多問題。我這裡只剩一個問題,想請你們更新一下 CD 的整合與綜效進展,以及定價能力如何?你們是否仍認為毛利率可以提升?
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Yeah, that's a good question, very good question. I mean, I think when we announced the deal, we really focused in on cost synergies that we were going to do, and we're on track to deliver those cost synergies that we had kind of laid out at the beginning.
是的,這是個好問題,非常好的問題。我的意思是,當我們宣布這筆交易時,我們確實把重點放在要實現的成本綜效上,而我們正按計畫交付一開始所規劃的那些成本綜效。
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
It's a 4 million annual cost synergies by the end of year three. (multiple speakers)
到第三年年底可達成每年 400 萬的成本綜效。(多位發言者)
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
We're on track to deliver those. I would sit there and say Oh beyond that, there are going to be what we call revenue synergies, but not revisited is just going out and getting more sales. But we did think there was a pricing opportunity. I would say we are running ahead of what we expected with really starting to take hold more in the back half of the year than in the front half, with contracts in inventory, some of these times you give price increases and it takes a quarter or two to actually start delivering of product at those new price levels.
我們正按計畫達成。我會說,除此之外,還會有所謂的營收綜效,但那不是重新檢討,而是單純出去拿到更多銷售。不過我們確實認為存在定價機會。我會說,我們的進展超出原先預期;真正開始更明顯發酵是在下半年而不是上半年,因為合約與庫存等因素,有時候你調漲價格後,實際以新價格水準交付產品,會需要一到兩個季度才會反映出來。
But we are expecting that we have quite nice pricing increases and our expectations is that when we bought this business, we were pretty clear it was in the low 30% in terms of gross margin that we think that that will be approaching like over 35% probably approaching 40% exiting the year. And so it's a combination of cost synergies as well as pricing.
但我們預期會有相當不錯的漲價幅度;而我們的預期是,當初收購這項業務時我們很清楚地說過,其毛利率大約在 30% 出頭,我們認為到年底時將接近超過 35%,可能接近 40%。因此這是成本綜效加上定價的組合。
And I think as we looked at '25, obviously, we didn't get all the pricing in this year because obviously it rolls through the year. If there's that you'll even with not doing another price increase, some of this will roll over into future price increases during the first two, three quarters of next year. So I think we're pretty excited about the opportunities in terms of synergy.
而且我想當我們看 2025 年時,很明顯地,我們今年並沒有把所有的定價都完全反映進來,因為它會在年度中逐步滾動。即使不再做下一次漲價,其中一部分也會在明年第一、第二、第三季以延續效應的方式反映出來。所以我想我們對綜效機會感到相當興奮。
And lastly, I just want to just look for one more piece on Cornell, I think you were really starting to understand a little bit better about some of the things that they do. They're very unique in terms of products. So there's going to be some opportunities. I think we'll probably talk about at an Investor Day later this year in some of the new markets that we probably will go after.
最後,我也想再補充一點關於 Cornell;我想你們確實開始更了解他們所做的一些事情。他們在產品方面非常獨特。所以會有一些機會。我想我們可能會在今年稍晚的投資人日談到一些我們可能會切入的新市場。
But I but I would also say is the strength that they have in distribution with our distribution distribution partners like Arrow and TTI is a great opportunity as for our legacy PT business to start getting more business in distribution. So obviously, that's not a short term thing like this year.
不過我也想說,他們在通路上的優勢,搭配我們的通路合作夥伴(例如 Arrow 和 TTI),對我們既有的 PT 業務而言,是一個在通路端取得更多業務的絕佳機會。所以很明顯,這不是像今年這樣的短期事情。
But I think overall, I think I think we couldn't be quite frankly, more pleased with this same kind of industrial distribution inventory issues that most people have been dealing with.
但整體而言,坦白說,即使面臨多數人都在處理的同樣工業通路庫存問題,我想我們再滿意不過了。
Pete Lukas - Analyst
Pete Lukas - Analyst
Very helpful. Thanks.
非常有幫助。謝謝。
Operator
Operator
Anthony Stoss, Craig Hallum Capital Group.
Anthony Stoss,Craig Hallum Capital Group。
Anthony Stoss - Analyst
Anthony Stoss - Analyst
Good afternoon, guys. I'm curious if you wouldn't mind sharing your view on either changes in your competitors in terms of their go to market or pricing within each of the segments. And also, it's nice to see PD up expected to be up each quarter sequentially. Can the same be said for the medtech group?
各位下午好。我想請教你們是否方便分享一下,你們對競爭對手在各個事業部門的市場進入策略或定價方面是否有變化的看法。另外,很高興看到你們預期 PD 每一季都會季增。Medtech 團隊也能這樣說嗎?
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Well, again, I would sit there and say for the full year, MSA will be up for the full year and growing in kind of that rate that we've kind of talked about in that 3% to 5% range. And so it does tend to be, as I kind of said, in the earlier question, a little bit more heavily weighted in terms of seasonally to Q4, but I don't have any big issues on this because we see this every year.
嗯,再次說明,我會說就全年而言,MSA 全年會成長,成長率大致落在我們先前談到的 3% 到 5% 區間。因此它確實如我在前一個問題所說,季節性上會比較偏向第四季,但我對此沒有任何重大疑慮,因為我們每年都會看到這種情況。
You can see Q4 always being the heaviest year within the MSA segment driven by the product launches of our customers. So that's I'd say about MSA as far as the competitive environment and let me cover by segment in the PT segment, no big changes, really. I think we have a lot of sole-source positions. I would just say the one thing, obviously people are hearing is a bit slower than probably we hope for.
你可以看到在 MSA 部門,第四季一向是全年最強,主要由客戶的產品上市所帶動。以上是 MSA 的部分;至於競爭環境,我按部門來說:在 PT 部門,基本上沒有什麼重大變化。我想我們有很多單一來源(sole-source)的供應地位。我只想說一點,顯然大家也聽到的是,進展比我們希望的稍微慢一些。
But as we kind of see a recovery, I think the one thing I'm very encouraged about in the PD is that we're seeing increasing gross margins throughout the year, which is showing that that we don't have to get back the 2022 levels in order to really get back to gross margins we saw back then.
但當我們看到復甦時,我對 PD 有一點非常受到鼓舞:我們看到毛利率在全年持續提升,這顯示我們不必回到 2022 年的水準,也能回到當時看到的毛利率水準。
And so I think there's some pricing in there. There's some productivity. There's obviously revenue growth and where we get the revenue growth helps us with some with capacity utilization MSA, I'd say the pricing environment is stable. That's what I would just say. There really isn't any change in the competitive environment, we know over the last year or so.
所以我想其中有一些定價因素。也有一些生產力提升。當然也有營收成長,而我們取得營收成長的組合也能在產能利用率方面帶來一些幫助。至於 MSA,我會說定價環境是穩定的。我就這麼說。競爭環境並沒有任何變化,和我們在過去一年左右所看到的一樣。
And I think you're in the CMM business. I think the other thing that we just keep saying, which is kind of like the last couple of quarters, which is mobile is a tough business and we are trying to kind of reduce our exposure over time to mobile. I think over the years at one point, our in our company was 35% mobile, last year was around 15%.
而且我認為你們是在做 CMM 業務。我認為我們一直在重申的另一點(有點像過去幾個季度一樣)是,行動裝置是一門艱難的生意,我們正試圖隨著時間推移逐步降低對行動端的曝險。我想多年來在某個時間點,我們公司行動端占比曾達 35%,去年大約是 15%。
I would say, we would expect it to be sub 15% this year as we continue to drive diversify the total company revenue kind of away from the mobile environment.
我會說,隨著我們持續推動公司整體營收多元化、逐步遠離行動端環境,我們預期今年會低於 15%。
Anthony Stoss - Analyst
Anthony Stoss - Analyst
Got it. Thanks for that, Jeff, and you guys are definitely outperforming your other mobile peers and chip plants. So congrats on that. That's all my questions. Thank you.
了解。謝謝你,Jeff,而且你們確實在行動端同業與晶片廠同儕中表現優於其他人。所以恭喜。我的問題就到這裡。謝謝。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Thanks, Anthony.
謝謝你,Anthony。
Operator
Operator
Thanks. (Operator Instructions) Tristan Gerra, Baird.
謝謝。(接線員指示) Tristan Gerra,Baird。
Tristan Gerra - Senior Research Analyst
Tristan Gerra - Senior Research Analyst
Hey, good afternoon. You've mentioned that most of the year-over-year growth embedded in your Q2 revenue guidance would be coming from Cornell. So I'm guessing a high $20 million, maybe $30 million in revenue in the quarter. Can you remind us of the seasonality of that business?
嗨,午安。你們提到,Q2 營收指引中所隱含的大部分年增成長將來自 Cornell。所以我猜該季度營收大概是 2,000 多萬美元、也許 3,000 萬美元。你能提醒我們這項業務的季節性嗎?
How does this tie to a full year revenue number. I'm guessing we're probably going to be below the $140 million-plus that you've talked about before, given the macro headwinds for coal now, but just wanted to kind of get an update on that.
這與全年營收數字如何連結?考量到目前煤炭的總體逆風,我猜我們可能會低於你們先前提到的 1.4 億美元以上,但想請你更新一下。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Yes. I wouldn't say there's a tremendous amount of seasonality, Tristan, in that business, but we are based on bookings. We are expecting to see sequential growth in Q3 and then sequential growth in Q4, again arms. And so what I would say is, we had said $140 million revenue and $26 million of EBITDA.
是的。Tristan,我不會說那項業務有非常明顯的季節性,但我們是以訂單(bookings)為基礎。我們預期 Q3 會季增,接著 Q4 也會再季增,再次強調。所以我會說,我們先前提到的是 1.4 億美元營收與 2,600 萬美元 EBITDA。
So it's probably going to be a touch short of the $140 million. I would say, right now, if you ask me between $135 million and $140 million probably for the year. But I think what asset level lower revenue will still hit the EBITDA number based on the synergies we've recognized. So I think we feel pretty good about that.
所以可能會略低於 1.4 億美元。我會說,如果你現在問我,今年大概會落在 1.35 億到 1.4 億美元之間。但我認為,即使資產層級的營收略低,基於我們已實現的綜效,仍會達到 EBITDA 的數字。所以我覺得我們對此相當有信心。
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
And the other thing I'd add, Tristan, in terms of the Cornell, we really are excited about the cash flow generation offered ability of that business where it's even -- as Jeff said, slightly lower revenue plan for 2024, the business is going to generate more cash flow than we envision that are in our model.
另外我想補充的是,Tristan,就 Cornell 而言,我們對那項業務所提供的現金流創造能力感到非常興奮;即便——如 Jeff 所說——2024 年的營收規劃略低,該業務仍將產生比我們模型中預期更多的現金流。
Tristan Gerra - Senior Research Analyst
Tristan Gerra - Senior Research Analyst
That's great. And then you talked about the positive pricing that you see in precision devices. Help us reconcile this with the overall environment, you know that we're seeing, you know, pricing stabilizing, meaning kind of returning to kind of low single digit declines. We see that in a in analog, we're seeing more pressure in MCUs up.
很好。接著你提到在精密元件(precision devices)看到正向的定價。請協助我們把這點與整體環境對照起來:我們看到定價趨於穩定,也就是回到低個位數的下滑。我們在類比(analog)看到這種情況,而在 MCU 則看到更多壓力。
So what's driving the pricing that you're able to implement, you know, in PDN? And if you could talk about general lead times and supply demand dynamics that you see in that space industry-wide, actually. So we cannot get a sense of what the landscape is with pricing going forward.
那麼,是什麼在驅動你們能在 PDN 推行的定價?另外,如果你能談談你在該領域(其實是整個產業)看到的一般交期與供需動態。好讓我們能掌握未來定價走勢的全貌。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Yes. So here's I kind of describe it. If you think about the markets that we really in precision devices are focused on, Medtech, defense, industrial and distribution.
是的。我大概這樣描述。如果你想想我們在精密元件真正聚焦的市場:醫療科技(Medtech)、國防、工業以及通路(distribution)。
Let me break those out in Medtech, though, in defense, we have a lot of sole-source positions where we have unique offering. This has kind of been the strategy all along where we're trying to move in a direction where we can provide differentiated products in these spaces and then have some amount of pricing power going forward.
我把它們拆開來說:在醫療科技與國防領域,我們有很多單一來源(sole-source)的地位,因為我們有獨特的產品供給。這一直是我們的策略:我們試圖朝著能在這些領域提供差異化產品的方向前進,並在未來具備一定程度的定價能力。
And so we feel pretty good about those end markets. Now distributions a little bit different of an animal fully as I've described, but here's what I'd say. I think we've talked about Cornell. Cornell shipped in 20 prior to 12 months prior to us owning it. They shipped to 30,000 unique customers.
因此我們對這些終端市場感覺相當不錯。至於通路則是另一種動物,正如我完整描述過的,但我會這麼說。我想我們談過 Cornell。Cornell 在我們收購前的 12 個月內出貨給——在此前 12 個月——他們出貨給 30,000 個獨立客戶。
And a lot of those are through distribution on a lot of them are customers that are sub [50 K] from. We kind of see that as an opportunity when we bought the business to say I'm just making these numbers up now, but would you raise prices by 5% on a $50,000 a year customer, you're raising prices by $2,500.
其中很多是透過通路出貨,且有不少客戶的規模低於 [50 K]。我們在收購這項業務時就把這視為一個機會:我現在只是隨便舉例,但如果你對一年 50,000 美元的客戶漲價 5%,等於漲了 2,500 美元。
And so we see that the value of that distribution market because what happens typically I've seen in distribution is if we raise prices to the smaller customers through distribution, the distributor just passes those on. And so the underlying demand is going to be what it's going to be, right.
因此我們看到了通路市場的價值,因為我通常在通路看到的是:如果我們透過通路對較小客戶調高價格,通路商就會把這些漲價轉嫁出去。所以底層需求會是它本來就會是的樣子,對吧。
Obviously, there are some challenges underlying demands and when it comes back, it will be better for it. And so overall, when I see this is the pricing environment for us because of our position in Medtech and defense coupled with distribution. We're not facing quite the kind of things that some of the things people our more commoditized products are.
顯然,底層需求確實有一些挑戰,但當它回來時,情況會更好。所以整體而言,這就是我們所處的定價環境:因為我們在醫療科技與國防的地位,再加上通路。我們面臨的狀況不像一些擁有更商品化產品的人那麼嚴峻。
Tristan Gerra - Senior Research Analyst
Tristan Gerra - Senior Research Analyst
Okay. That's great. So it sounds like the pricing optimization opportunity is really on the Cornell side. Outside of that, would you say that pricing is stable in the rest of your Precision Device business?
好的。很棒。所以聽起來,定價最佳化的機會主要是在 Cornell 這一端。除此之外,你會說你們精密元件業務其餘部分的價格是穩定的嗎?
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
No, I would say that prices are probably still going to be up in the rest of precision devices. But here's the differences. What we've done in Cornell in terms of pricing this year under the ownership, we did we went to the same I think, three, four years ago in overall precision devices.
不,我會說精密元件其餘部分的價格可能仍會上升。但差異在這裡。我們今年在 Cornell、在收購後所做的定價調整,其實就是我們在整體精密元件業務中大概三、四年前做過的那一套。
So the amount we're getting in any given year with the legacy PD, is not going to be as large as the first, what we saw in core and the Cornell opportunity. So I think from our perspective is we're still getting some price this year in the legacy PD, but the Cornell, it was an untapped opportunity that we've figured out and we're taking advantage of.
因此,既有 PD 在任何一年能取得的漲價幅度,不會像我們在 Cornell 機會上最初看到的那麼大。所以從我們的角度來看,既有 PD 今年仍有一些漲價,但 Cornell 是一個我們已找出並正在加以利用的、先前未被開發的機會。
Tristan Gerra - Senior Research Analyst
Tristan Gerra - Senior Research Analyst
Great. Thank you very much.
很好。非常感謝。
Operator
Operator
(Operator Instructions) There are no further questions at this time. This concludes today's call. Thank you all for joining. You may now disconnect.
(接線員指示) 目前沒有其他問題。今天的電話會議到此結束。感謝各位參與。您現在可以掛線。